论文部分内容阅读
目的探讨介入溶栓治疗急性脑梗死的临床效果。方法选择2014年12月-2016年12月在吉林市中心医院接受治疗的急性脑梗死患者45例作为研究对象,对其临床资料进行回顾性分析。采用Seldinger技术,在患者体内置入6F导管,采用肝素进行抗凝治疗。同时,采用全脑血管造影技术,将患者的导管置入梗塞供血血管中,运用尿激酶进行治疗,观察患者血管溶栓效果。结果在本次研究中,本组45例患者经过动脉溶栓治疗,完全再通率为33.33%,部分再通率为57.78%,未通率为8.89%,运动障碍患者功能改善30例,语言障碍好转25例,意识恢复清醒2例,1例意识障碍患者没有明显的好转。并发症发生率为4.44%。结论采用尿激酶进行介入溶栓治疗,有着较高的安全性与效果,是临床治疗急性脑梗死的重要方法,应当予以推广。
Objective To investigate the clinical effect of interventional thrombolysis in acute cerebral infarction. Methods Forty-five patients with acute cerebral infarction who were treated in Jilin Central Hospital from December 2014 to December 2016 were selected as the research object, and their clinical data were retrospectively analyzed. Using Seldinger technology, a 6F catheter was placed in the patient and heparin was used for anticoagulation. At the same time, using whole-brain angiography, the patient’s catheter into the infarction blood vessels, the use of urokinase for treatment, observation of patients with thrombolytic effect. Results In this study, 45 patients in this group were treated with thrombolytic therapy. The complete recanalization rate was 33.33%, the partial recanalization rate was 57.78%, the failure rate was 8.89%, the dyskinesia function was improved in 30 cases, and the language Obstacles improved in 25 cases, conscious recovery in 2 cases, 1 case of disturbance of consciousness did not significantly improved. The complication rate was 4.44%. Conclusion Urokinase is an effective and safe method for the treatment of acute cerebral infarction. It should be popularized.